Treatment of Bacterial Vaginosis
Metronidazole 500 mg orally twice daily for 7 days is the recommended first-line treatment for bacterial vaginosis due to its high efficacy rate of 95% and established safety profile. 1
Diagnosis Criteria
Before initiating treatment, bacterial vaginosis should be diagnosed using the Amsel clinical criteria, which requires 3 of the following 4 findings:
- Homogeneous, white vaginal discharge that adheres to vaginal walls
- Presence of clue cells on microscopic examination
- Vaginal fluid pH greater than 4.5
- Fishy odor when 10% KOH is added to vaginal discharge (positive whiff test)
Alternatively, Gram stain of vaginal smear (Nugent score ≥4) can be used as a laboratory method for diagnosis 1.
Treatment Options
First-Line Treatments (Recommended Regimens)
Metronidazole 500 mg orally twice daily for 7 days 1
- Highest cure rate (95%) among all regimens 1
- Most extensively studied treatment option
Metronidazole gel 0.75%, one full applicator (5 g) intravaginally, once daily for 5 days 1
- Good option for patients who cannot tolerate oral therapy
- Lower systemic absorption (2% of oral dose) 1
Clindamycin cream 2%, one full applicator (5 g) intravaginally at bedtime for 7 days 1
- Alternative for patients with metronidazole allergy
- Slightly less efficacious than metronidazole regimens 1
Alternative Regimens
Metronidazole 2 g orally in a single dose 1
- Lower efficacy (84%) compared to 7-day regimen 1
- Better for patients with adherence concerns
Clindamycin 300 mg orally twice daily for 7 days 1
- Alternative for metronidazole-allergic patients
Clindamycin ovules 100 g intravaginally once at bedtime for 3 days 1
- Convenient shorter course option
Tinidazole 2 g once daily for 2 days or 1 g once daily for 5 days 2
- FDA-approved alternative with similar efficacy to metronidazole
Special Considerations
Pregnancy
- For pregnant women in first trimester: Clindamycin vaginal cream is preferred due to contraindication of metronidazole 1
- For second and third trimesters: Oral metronidazole can be used 1
- High-risk pregnant women (previous preterm birth) with asymptomatic BV may benefit from treatment to reduce preterm delivery risk 1
Pre-Surgical Prophylaxis
- Consider screening and treating BV before surgical abortion or hysterectomy to reduce post-operative infectious complications 1
- Treatment has been shown to reduce post-abortion PID by up to 75% 1
Recurrent BV
- Recurrence rates are high (50-80% within one year) 3, 4
- For recurrent cases, extended course of metronidazole (500 mg twice daily for 10-14 days) is recommended 4
- Alternative: metronidazole vaginal gel 0.75% for 10 days, followed by twice weekly for 3-6 months 4
Important Precautions
- Patients should avoid alcohol during treatment with metronidazole and for 24 hours afterward due to potential disulfiram-like reaction 1
- Clindamycin cream and ovules are oil-based and may weaken latex condoms and diaphragms 1
- Treatment of male sexual partners is not recommended as it does not reduce recurrence rates 1
- Follow-up visits are unnecessary if symptoms resolve 1
Treatment Efficacy
- Oral metronidazole (7-day regimen): 95% cure rate
- Oral metronidazole (single dose): 84% cure rate
- Intravaginal treatments: Similar efficacy to oral regimens with fewer systemic side effects 1, 5
BV treatment should focus on symptom relief and prevention of complications, particularly in pregnant women or those undergoing invasive gynecological procedures.